Biotek-snakken — Juni 2021
-
Aktier/tendens: Let positive tendenser men næppe for Orphazyme https://www.proinvestor.com/investornyt/676191/aktier-tendens-let-positive-
tendenser-men-naeppe-for-orphazyme -
Four Biotech Names To Watch
https://www.proinvestor.com/index.php?p=debat_1&postid=94411 -
Orphazyme -75%
-
Kurs 23,7
-
Trist for aktionærere men langt mere trist for dem der potentielt kunne behandles:(
-
Trist udvikling. Jeg håber ikke der er for mange herinde, som fik ørene i ma
skinen. -
Servicemedelelse: Vort nye gratis fredags nyhedsbrev har fået en fantastisk modtagelse. Har du endnu ikke meldt dig til kan du gøre det her: https://proinvestor.us2.list-manage.com/subscribe/post?u=f105e51cabee2948f03126a1e&id=9e51525eeb
-
Orphazyme/Nordnet: Kursfald på 65 pct. er billigt sluppet
https://www.proinvestor.com/investornyt/676201/orphazyme-nordnet-kursfald-pa-65-pct-er-billigt-sluppet -
"kurs 5 idag" Ej heller her. Desværre, så vil det heller ikke undre om der går Gamestop i den når US åbner.
Sorteper regler - Spilregler.dk
Sorteper er oprindeligt et børnespil med dyremotiver som pares to og to, men et almindeligt kortspil kan anvendes. Formålet med spillet er at undgå Sorteper
Spilregler.dk (spilregler.dk)
-
HC Wainwright & Co. Initiates Coverage On Sutro Biopharma with Buy Rating, Announces Price Target of $35
HC Wainwright & Co. analyst Andrew Fein initiates coverage on Sutro Biopharma (NASDAQ:STRO) with a Buy rating and announces Price Target of $35.
Benzinga (www.benzinga.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind